Steven J. Rice - 17 Feb 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Chief Administrative Officer
Signature
/s/ Howard Horn, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
17 Feb 2022
Net transactions value
-$62,010
Form type
4
Filing time
22 Feb 2022, 16:01:37 UTC
Previous filing
02 Dec 2021
Next filing
24 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Sale $62,010 -1,942 -9.4% $31.93 18,658 17 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.